Niall Collins
Question:915. Deputy Niall Collins asked the Minister for Health the status of the cross-border directive since 1 January 2021 in the context of Brexit; and if he will make a statement on the matter. [1056/21]
View answerWednesday, 13 January 2021
Questions (915)
Written answers
Since 1 January 2021, the provisions of the EU Cross Border Directive (CBD) no longer apply to the UK. In order to mitigate the impact of the loss of access to care in the UK under the EU CBD scheme for persons resident in Ireland, the Government has agreed to provide for the implementation of a replacement scheme to be available in Northern Ireland only from 1 January 2021. The new Northern Ireland Planned Healthcare Scheme will operate for 12 months and will operate on the same parameters as the EU Cross Border Directive scheme.
Furthermore, the HSE has also put in place transitional arrangements for certain patients who have a legitimate expectation of continuing to access care in the UK under the current provisions of the EU Cross-Border Directive Scheme including provision for reimbursement of healthcare costs by the HSE to persons who fall into certain categories, such as patients who can evidence that they have treatment booked prior to December 2020 for treatment in 2021. Patients are advised to contact the HSE CBD office directly with queries on individual applications and whether they are covered by the transitional arrangements or the new Northern Ireland Planned Healthcare Scheme.
Finally, it is also important to note that, patients continue to have access to health services under the EU CBD Scheme in all other remaining EU countries.